Targeting the nitric oxide/cGMP signaling pathway to treat chronic pain

Targeting the nitric oxide/cGMP signaling pathway to treat chronic pain

Nitric oxide (NO)/cyclic guanosine 3′,5′-monophosphate (cGMP) signaling has been shown to act as a mediator involved in pain transmission and processing. In this review, we summarize and discuss the mechanisms of the NO/cGMP signaling pathway involved in chronic pain, including neuropathic pain, bon...

Full description

Bibliographic Details
Main Authors: Dan-Yang Li, Shao-Jie Gao, Jia Sun, Long-Qing Zhang, Jia-Yi Wu, Fan-He Song, Dai-Qiang Liu, Ya-Qun Zhou, Wei Mei
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Neural Regeneration Research
Subjects:
bone cancer pain; chronic pain; cyclic gmp; dorsal root ganglion; inflammatory pain; morphine tolerance; neuropathic pain; nitric oxide; protein kinase g; spinal cord
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=5;spage=996;epage=1003;aulast=Li

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=5;spage=996;epage=1003;aulast=Li

Similar Items